Literature DB >> 19448669

v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.

S Steinmann1, K Schulte, K Beck, S Chachra, T Bujnicki, K-H Klempnauer.   

Abstract

Myc, a key regulator of cellular proliferation, differentiation and apoptosis, exerts its biological functions by activating or suppressing the transcription of specific sets of target genes. C/EBP transcription factors play important roles during differentiation of various cell types and have been identified as critical targets for v-Myc- and c-Myc-dependent suppression of myeloid and fat cell differentiation. Here, we have addressed the mechanism by which v-Myc suppresses the activity of C/EBPbeta. We show that v-Myc is recruited to the aminoterminal domain of C/EBPbeta and interferes with the cooperation of C/EBPbeta and the co-activator p300 by preventing C/EBPbeta-induced phosphorylation of p300. We have identified the protein kinase responsible for C/EBPbeta-induced phosphorylation of p300 as homeo-domain interacting protein kinase 2 (HIPK2) and show that v-Myc displaces the kinase from the C/EBPbeta-p300 complex. Overall, our findings that the modulation of the C/EBPbeta-induced phosphorylation of p300 as a new mechanism of transcriptional suppression by v-Myc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448669     DOI: 10.1038/onc.2009.90

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.

Authors:  Anke Jakobs; Simone Steinmann; Sarah Marie Henrich; Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

2.  Transcriptional repression: the dark side of myc.

Authors:  Barbara Herkert; Martin Eilers
Journal:  Genes Cancer       Date:  2010-06

3.  Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.

Authors:  Farzin Pourfarzad; Marieke von Lindern; Azita Azarkeivan; Jun Hou; Sima Kheradmand Kia; Fatemehsadat Esteghamat; Wilfred van Ijcken; Sjaak Philipsen; Hossein Najmabadi; Frank Grosveld
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

4.  Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.

Authors:  Prasenjit Bhaumik; Jamaine Davis; Joseph E Tropea; Scott Cherry; Peter F Johnson; Maria Miller
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-06-29

5.  Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).

Authors:  Simone Steinmann; Anna Coulibaly; Johanna Ohnheiser; Anke Jakobs; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

6.  The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.

Authors:  Anna Coulibaly; Astrid Haas; Simone Steinmann; Anke Jakobs; Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.